Valproic acid and immune thrombocytopenia.
Open Access
- 1 September 1982
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 57 (9) , 681-684
- https://doi.org/10.1136/adc.57.9.681
Abstract
During the course of a prospective serial study over a period of one year, findings compatible with immune-mediated thrombocytolysis accompanied the administration of valproic acid in about half of 45 children with epilepsy. Thrombocytopenia occurred in 15 and neutropenia in 12 patients, but was transient and self-limiting in each. The association is probably one of cause and effect, and it may reflect the structural similarity between valproic acid and constituents of cell membranes.This publication has 18 references indexed in Scilit:
- Individualized Patient Assessment in the Treatment of Epilepsy with Sodium ValproateEpilepsia, 1980
- Sodium valproate and platelet counts.BMJ, 1980
- Interaction between sodium valproate and platelets: a further study.BMJ, 1979
- Neutropenia during sodium valproate treatment.Archives of Disease in Childhood, 1979
- Valproic AcidArchives of Neurology, 1979
- IgM platelet autoantibody due to sodium valproate.BMJ, 1978
- SODIUM VALPROATE AND PLATELET-COUNTThe Lancet, 1978
- Sodium valproate and thrombocytopenia.BMJ, 1976
- Letter: Sodium valproate and platelet function.BMJ, 1976
- Sodium valproate and platelet function.BMJ, 1976